会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • CORRECTION FACTOR TESTING USING FREQUENT BLOOD GLUCOSE INPUT
    • 使用常规血糖葡萄糖输入的校正因子测试
    • WO2008091320A3
    • 2009-04-30
    • PCT/US2007024424
    • 2007-11-26
    • SMITHS MEDICAL MD INCBLOMQUIST MICHAELPOPE RHALL E
    • BLOMQUIST MICHAELPOPE RHALL E
    • G06F19/00
    • A61M5/1723A61M5/14244A61M2205/50A61M2230/201G06F19/3468
    • An apparatus comprising a user interface configured to generate an electrical signal to begin determination of an effective correction factor when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, and a controller in electrical communication with the input and the user interface. The controller includes a correction factor module configured for determining an effective correction factor according to an amount of insulin in the initial insulin correction bolus and a decrease in the blood glucose level determined using the sampled blood glucose data. Other devices and methods are disclosed.
    • 一种装置,包括用户界面,所述用户界面被配置为在用户提示时产生电信号以开始确定有效的校正因子,所述输入被配置为接收在指定的持续时间内获得的患者的取样的血糖数据,所述输入包括时间 在输送初始胰岛素补正推注之后的持续时间,以及与输入和用户界面电通信的控制器。 控制器包括校正因子模块,其被配置为根据初始胰岛素校正推注中的胰岛素量确定有效的校正因子,并且使用采样的血糖数据确定血糖水平的降低。 公开了其他装置和方法。